Frost & Sullivan Recognizes OmniActive Health Technologies for 2017 North American Product Leadership with Unique Macular Carotenoid Ingredient - Seite 2

"With increasing awareness and concern among consumers about eye health, it is imperative that eye health ingredient companies understand the rising market demand and speed up research processes for eye health ingredients that meet consumers' needs, including demonstrating the short- and long-term benefits of macular carotenoids," said Arun Ramesh, Industry Analyst.

OmniActive's goal is to broaden the appeal and market opportunities for macular carotenoids through an ambitious plan that includes:

• Formula development and clinical research
• Sustainable farming and vertically integrated manufacturing
• Consumer research and educational outreach

"We are honored to receive this award which is a true testament to the uniqueness of Lutemax^® 2020. Sustainably-sourced from a fully integrated supply chain, Lutemax^® 2020 delivers all three macular carotenoids for a more complete formulation," said Lynda Doyle, Sr. VP Global Marketing at OmniActive Health Technologies. "Supported by strong science including the B.L.U.E. (Blue Light User Exposure) study, Lutemax^® 2020 is the first and only macular carotenoid ingredient which showed beneficial effects on vision health and performance, sleep quality as well as reducing eye strain and fatigue during long-duration exposure to blue light which addresses the needs of modern lifestyles."

Through its internal quality tests and studies done in partnership with universities, the company has developed multi-step quality control processes, including its PlantActive™ Verification program, which employs DNA barcoding and HPLC (high-performance liquid chromatography) analysis to ensure authenticity and consistency that comply with proposed NDI (New Dietary Ingredients) regulations. 

Frost & Sullivan analysis concludes that OmniActive Health Technologies' proprietary product, Lutemax^® 2020, addresses industry challenges by offering eye, skin, and brain health benefits from a single, ingredient. In addition, the company has created strong visibility in the market through campaigns depicting the health benefits of macular carotenoids. Through consistent investments in R&D, this pioneering company continues to broaden its scientific substantiation on eye health ingredients and focuses on new studies that support bioavailability, visual function, and, more importantly, emphasize the benefits of macular carotenoids to support visual function during prolonged digital screen exposure. For these reasons, OmniActive Health Technologies has earned Frost & Sullivan's 2017 North American Product Leadership Award.